Incidence of fatigue symptoms and diagnoses presenting in UK primary care from 1990 to 2001.
Gallagher, Arlene M, Thomas, Janice M, Hamilton, William T et al. · Journal of the Royal Society of Medicine · 2004 · DOI
Quick Summary
This study looked at how often fatigue and related diagnoses were recorded in UK doctor's offices between 1990 and 2001. While the overall number of fatigue diagnoses decreased, the number of people diagnosed with ME/CFS and fibromyalgia actually increased during this time. Interestingly, the number of people reporting fatigue symptoms stayed roughly the same, suggesting that doctors may have simply changed how they labeled and diagnosed these conditions rather than there being a real change in how many people were affected.
Why It Matters
This study challenges assumptions about whether ME/CFS is becoming more common, suggesting instead that increased diagnosis rates reflect evolving clinical recognition and terminology rather than true increases in disease incidence. Understanding these diagnostic trends helps patients contextualize epidemiological claims and informs discussions with healthcare providers about why diagnosis patterns have shifted over time.
Observed Findings
Overall fatigue diagnoses decreased 44% between 1990 and 2001 (from 87 to 49 per 100,000 patients).
CFS/ME increased from 9% to 26% of all fatigue diagnoses during the study period.
Fibromyalgia diagnoses increased dramatically from less than 1 to 35 per 100,000.
Incidence of recorded fatigue symptoms remained relatively stable at approximately 1,503 per 100,000 annually (1.5% per year).
All fatigue symptoms and diagnoses were consistently more common in females than males across the study period.
Inferred Conclusions
The rise in CFS/ME and fibromyalgia diagnoses against a background of stable symptom reporting likely reflects changes in diagnostic labeling and clinical fashion rather than true increases in disease incidence.
The shift away from postviral fatigue syndrome diagnoses (81% to 60%) toward more specific diagnostic categories suggests evolving clinical terminology and recognition practices.
Diagnostic trends in primary care may be influenced by factors other than actual disease prevalence, including changes in clinical awareness and diagnostic criteria.
Remaining Questions
Did the diagnostic criteria used by clinicians for CFS/ME or fibromyalgia actually change during this period, and if so, how did these changes relate to increased diagnosis rates?
What This Study Does Not Prove
This study does not prove that ME/CFS is not a real condition or that patients' symptoms were not genuine. It also cannot determine whether improved recognition of ME/CFS in later years was appropriate or whether some diagnoses were accurate—only that diagnostic labeling changed while underlying symptom reporting remained stable. The study's reliance on documented diagnoses means it cannot account for undiagnosed cases.
What proportion of the increased CFS/ME diagnoses represented previously unrecognized cases versus relabeling of conditions previously coded differently?
How do primary care diagnostic patterns compare to specialist clinic diagnoses, and did the relationship between primary and specialist diagnosis change over the decade?
What factors drove the dramatic increase in fibromyalgia diagnoses, and did clinical practice guidelines or pharmaceutical marketing play a role?